the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Ex-prince Andrew ignores US lawmakers’ deadline in Epstein inquiry

Britain’s former prince Andrew failed to respond to US lawmakers’ request for testimony about Jeffrey Epstein by the November 20 deadline

WASHINGTON: Britain’s disgraced former prince Andrew failed to respond to a US Congressional request for testimony about his friendship with convicted sex offender Jeffrey Epstein.

Sixteen Democratic lawmakers had asked Andrew to participate in a transcribed interview with the House oversight committee investigating Epstein.

The letter requested a response by November 20 from Andrew, now known as Andrew Mountbatten-Windsor after being stripped of royal titles.

US Congress cannot compel testimony from foreigners, making Andrew’s cooperation unlikely from the outset.

“Andrew Mountbatten-Windsor’s silence in the face of the Oversight Democrats’ demand for testimony speaks volumes,” committee members Robert Garcia and Suhas Subramanyan said in a statement.

“The documents we’ve reviewed, along with public records and Virginia Roberts Giuffre’s testimony, raise serious questions he must answer, yet he continues to hide.”

Recently released committee emails and Giuffre’s posthumous memoir reignited anger over Andrew’s Epstein ties in the UK.

Andrew has consistently denied sexually abusing Giuffre, who alleged she was trafficked to have sex with him three times, twice when she was 17.

He paid her a multi-million-pound settlement in 2022 without admitting guilt after she sued him.

Giuffre died by suicide at her Australian home in April.

The committee members said their investigation into Epstein’s network would “move forward with or without” testimony from the 65-year-old Andrew.

“We will hold anyone who was involved in these crimes accountable, no matter their wealth, status, or political party,” they stated. “We will get justice for the survivors.” – AFP

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Addressing medical inflation

Consumers are struggling as medical insurance premiums surge, with over 340,000 dropping coverage amid calls for price regulation and stronger public healthcare

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings